I would choose healthcare reform, particularly companies exposed to Medicaid and ACA insurance markets.

The opportunity is not simply increased healthcare funding. It is reduced policy uncertainty. Centene ($CNC), Molina Healthcare ($MOH), and HCA Healthcare ($HCA) could benefit if Medicaid cuts are delayed or ACA subsidies restored.

However, political promises are not earnings growth. Senate voting requirements and Trump's veto power make sweeping reforms difficult. The new Congress also takes office only in January 2027.

I would monitor legislative progress, medical cost ratios, and earnings guidance rather than chase election-driven rallies.

The real opportunity is finding companies whose profits can improve even if only part of the proposed reforms becomes reality.

@Tiger_comments [真香]